Dollar rebounds despite Fed independence worries; euro slips
NEW YORK - On Friday, Avient Corporation (NYSE:AVNT) reported second quarter 2025 earnings that exceeded analyst expectations, driven by growth in defense and healthcare markets.
The materials solutions innovator’s shares rose 2.47% in pre-market trading after the release.
The company posted adjusted earnings per share of $0.80, surpassing the analyst consensus of $0.79, while revenue reached $866.5 million, beating estimates of $853.32 million. Revenue grew 2% compared to $849.7 million in the same quarter last year, with foreign exchange contributing 1% to the increase.
"On behalf of our entire Avient team, I’m pleased to report organic revenue growth for the fifth consecutive quarter driven by our focus on executing our strategy," said Dr. Ashish Khandpur, Chairman, President and Chief Executive Officer of Avient Corporation.
The company’s performance was bolstered by strong demand in defense and healthcare sectors, which grew by double digits during the quarter, offsetting weakness in consumer markets. Adjusted EBITDA margins expanded 30 basis points to 17.2% compared to the prior year period.
For the full year 2025, Avient narrowed its adjusted EPS guidance range to $2.77-$2.87 from the previous $2.70-$2.94. The midpoint of $2.82 represents continued confidence in the company’s outlook. For the third quarter, Avient expects adjusted EPS of $0.70, representing 8% growth over the prior year quarter.
"We expect momentum from our high-profit portfolios in defense and healthcare markets, along with disciplined cost controls and productivity initiatives, to contribute to continued margin expansion over the prior year," said Jamie Beggs, Senior Vice President and Chief Financial Officer.
The company also reported strong cash flow from operations of $113 million in the quarter, which supported $50 million of debt repayment. Avient remains on track to reduce debt by $100-$200 million by year-end.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.